Braving the Storm: How Music and Family Helped Tara Get Through a Tough, Rare, Little-Known Disease
Source: Pixabay

Braving the Storm: How Music and Family Helped Tara Get Through a Tough, Rare, Little-Known Disease

I know you’re fighting hard//I see your battle scars     It’s clear you’ve come so far//You’ll grow stronger Alone, these words may feel like just expressions of encouragement; a…

Continue Reading Braving the Storm: How Music and Family Helped Tara Get Through a Tough, Rare, Little-Known Disease
Anti-Psychotic Drug Could Prolong The Lives of Amyotrophic Lateral Sclerosis Patients
Pexels / Pixabay

Anti-Psychotic Drug Could Prolong The Lives of Amyotrophic Lateral Sclerosis Patients

According an article from CityNews Toronto, an anti-psychotic medication is undergoing clinical trials in the treating of amyotrophic lateral sclerosis. In other studies, the treatment has shown to help slow…

Continue Reading Anti-Psychotic Drug Could Prolong The Lives of Amyotrophic Lateral Sclerosis Patients
Midatech Pharma Gets Verbal Approval For MTD201 Continued Development
Source: Pixabay

Midatech Pharma Gets Verbal Approval For MTD201 Continued Development

Midatech Pharma just received verbal confirmation from Polish regulators to conduct the first European in-human study for a treatment that could potential aid those with carcinoid cancer and acromegaly, reported…

Continue Reading Midatech Pharma Gets Verbal Approval For MTD201 Continued Development
This Tournament is Raising Money for Colitis and Crohn’s Disease Research
source: pixabay.com

This Tournament is Raising Money for Colitis and Crohn’s Disease Research

According to a story from Syosset Jericho Tribune, the charity basketball fundraiser called Hoops for Harrison is back again this year. The tournament was named after Harrison Gillman, who now…

Continue Reading This Tournament is Raising Money for Colitis and Crohn’s Disease Research
Report: Pharma Can Resume Testing Drug Efficacy for Neurological and Respiratory Conditions
Source: Pixabay

Report: Pharma Can Resume Testing Drug Efficacy for Neurological and Respiratory Conditions

RespireRx Pharmaceuticals announced last month it was cleared to resume its ampakine CX717 clinical trials to evaluate the drug’s efficacy in several central nervous system and respiratory disorders, including Pompe…

Continue Reading Report: Pharma Can Resume Testing Drug Efficacy for Neurological and Respiratory Conditions